Blood transfusion

Reasons for the decision

Whilst there was new evidence across several areas, including red blood cells, platelets and cryoprecipitate, the evidence generally supported existing recommendations or did not provide a sufficiently strong case for update due to uncertainty in trial results or unclear benefits of interventions. Stakeholders generally agreed with the proposal not to update the guideline.

For further details and a summary of all evidence identified in surveillance, see appendix A.